Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
23.77
+0.38 (1.60%)
At close: Feb 21, 2025, 4:00 PM
23.81
+0.04 (0.19%)
After-hours: Feb 21, 2025, 7:03 PM EST
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $1.36 billion as of February 21, 2025. Its market cap has decreased by -37.66% in one year.
Market Cap
1.36B
Enterprise Value
449.90M
1-Year Change
-37.66%
Ranking
Category
Stock Price
$23.77
Market Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $1.36B, an increase of 147.95%. That is a compound annual growth rate of 55.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 1.34B | -13.75% |
| Dec 31, 2024 | 1.55B | -22.02% |
| Dec 29, 2023 | 1.99B | 262.83% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.92B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |